Peng Wang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Peng Wang has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
Xiu Mei Ma
Department of Endocrinology and Metabolism The Affiliated Hospital of Southwest Medical University Luzhou PR China
2 shared publicationsZong Zhe Jiang
Department of Endocrinology and Metabolism The Affiliated Hospital of Southwest Medical University Luzhou PR China
2 shared publicationsChen Lin Gao
Department of Endocrinology and Metabolism The Affiliated Hospital of Southwest Medical University Luzhou PR China
1 shared publicationKang Geng
Faculty of Chinese Medicine Macau University of Science and Technology Macau People's Republic of China
1 shared publicationPei Yu Yan
Faculty of Chinese Medicine Macau University of Science and Technology Macau People's Republic of China
1 shared publicationWei Huang
Department of Endocrinology and Metabolism The Affiliated Hospital of Southwest Medical University Luzhou PR China
1 shared publication
Latest Publications
- 23 February 2024
- Published by Wiley in Phytotherapy Research
- Vol. 38 (5) , 2154-2164
Effect of proanthocyanidins on blood lipids: A systematic review and meta‐analysis
Proanthocyanidins (PCs) are natural antioxidant polyphenols and their effect on the regulation of blood lipids is still controversial. This study was conducted to evaluate the effect of PCs on lipid metabolism. We searched PubMed, Embase, Web of Science, Chinese biomedical literature service system, China National Knowledge Internet, and Wanfang Data with no time restriction until March 18, 2022, using various forms of “proanthocyanidins” and “blood lipid” search terms. Randomized controlled trials investigating the relationship between PCs and lipid metabolism were included. The standard system of Cochrane Collaboration was used to assess the quality of studies. We standardized mean differences (SMDs) with 95% confidence interval (CI) using the random‐effects model, Cohen approach. Seventeen studies (17 trials, N = 1138) fulfilled the eligibility criteria. PCs significantly reduced triglyceride, and increased recombinant apolipoprotein A1. Subgroup analysis showed a significant reduction in triglycerides in older adults (≥60 years) and total cholesterol for participants who were not overweight or obese (body mass index <24). An intervention duration of greater than 8 weeks reduced triglyceride and low‐density lipoprotein cholesterol levels but increased high‐density lipoprotein cholesterol. Different doses of PCs could regulate triglycerides, high‐density lipoprotein cholesterol and total cholesterol. PCs have beneficial effects on circulating lipids and may represent a new approach for treating or preventing lipid metabolism disorders. However, more high‐quality studies are needed to confirm these results.
- 23 February 2024
- Published by Wiley in Phytotherapy Research
- Vol. 38 (5) , 2154-2164
Effect of proanthocyanidins on blood lipids: A systematic review and meta‐analysis
Proanthocyanidins (PCs) are natural antioxidant polyphenols and their effect on the regulation of blood lipids is still controversial. This study was conducted to evaluate the effect of PCs on lipid metabolism. We searched PubMed, Embase, Web of Science, Chinese biomedical literature service system, China National Knowledge Internet, and Wanfang Data with no time restriction until March 18, 2022, using various forms of “proanthocyanidins” and “blood lipid” search terms. Randomized controlled trials investigating the relationship between PCs and lipid metabolism were included. The standard system of Cochrane Collaboration was used to assess the quality of studies. We standardized mean differences (SMDs) with 95% confidence interval (CI) using the random‐effects model, Cohen approach. Seventeen studies (17 trials, N = 1138) fulfilled the eligibility criteria. PCs significantly reduced triglyceride, and increased recombinant apolipoprotein A1. Subgroup analysis showed a significant reduction in triglycerides in older adults (≥60 years) and total cholesterol for participants who were not overweight or obese (body mass index <24). An intervention duration of greater than 8 weeks reduced triglyceride and low‐density lipoprotein cholesterol levels but increased high‐density lipoprotein cholesterol. Different doses of PCs could regulate triglycerides, high‐density lipoprotein cholesterol and total cholesterol. PCs have beneficial effects on circulating lipids and may represent a new approach for treating or preventing lipid metabolism disorders. However, more high‐quality studies are needed to confirm these results.
- 5 October 2022
- Published by Wiley in Phytotherapy Research
- Vol. 36 (11) , 4051-4062
Effects of Camellia tea and herbal tea on cardiometabolic risk in patients with type 2 diabetes mellitus: A systematic review and meta‐analysis of randomized controlled trials
Evidence for the anti‐diabetic actions of camellia and herbal tea in diabetic patients has not been summarized. Several data sources were searched for randomized trials assessing the effect of different teas on cardiometabolic risk factors in T2D subjects. Two independent reviewers extracted relevant data and assessed the risk of bias. Results were summarized using mean differences (MDs) based on a random model. Sixteen studies (19 trials, N = 832) fulfilled the eligibility criteria. Mean differences were measured for body weight, body mass index, fasting blood glucose, glycosylated hemoglobin, a homeostatic model for insulin resistance, high and low‐density lipoproteins, triglycerides, and systolic and diastolic blood pressure. No effects on total cholesterol and waist circumference were observed when either camellia or herbal tea was consumed. Tea produced moderate regulatory effects on adipose, glycemic control, lipid profiles, and blood pressure. In terms of efficacy, camellia and herbal teas yield different benefits in regulating metabolism. This discovery has some implications for clinical research and drug development. However, more high‐quality trials are needed to improve the certainty of our estimates.
- 5 October 2022
- Published by Wiley in Phytotherapy Research
- Vol. 36 (11) , 4051-4062
Effects of Camellia tea and herbal tea on cardiometabolic risk in patients with type 2 diabetes mellitus: A systematic review and meta‐analysis of randomized controlled trials
Evidence for the anti‐diabetic actions of camellia and herbal tea in diabetic patients has not been summarized. Several data sources were searched for randomized trials assessing the effect of different teas on cardiometabolic risk factors in T2D subjects. Two independent reviewers extracted relevant data and assessed the risk of bias. Results were summarized using mean differences (MDs) based on a random model. Sixteen studies (19 trials, N = 832) fulfilled the eligibility criteria. Mean differences were measured for body weight, body mass index, fasting blood glucose, glycosylated hemoglobin, a homeostatic model for insulin resistance, high and low‐density lipoproteins, triglycerides, and systolic and diastolic blood pressure. No effects on total cholesterol and waist circumference were observed when either camellia or herbal tea was consumed. Tea produced moderate regulatory effects on adipose, glycemic control, lipid profiles, and blood pressure. In terms of efficacy, camellia and herbal teas yield different benefits in regulating metabolism. This discovery has some implications for clinical research and drug development. However, more high‐quality trials are needed to improve the certainty of our estimates.